Former GE Healthcare (NYSE:GE) head John Flannery will be stepping into the corner office for all of GE, replacing Jeff Immelt who is stepping aside after 16 years as head of the large conglomerate. The CEO transition will go into effect Aug. 1, while Flannery will also take over as board chair after Immelt retires on […]
Delphi Medical Systems
MASSDEVICE ON CALL — More researchers are finding evidence of misused heart therapies that may be costing thousands of lives each year, making the case that both underuse and overuse of implanted cardioverter defibrillators and cardiac resynchronization therapies are a problem in the health care industry.
Earlier this year researchers found that more than one in five patients implanted with ICDs may not have needed the device. The study, published in the Journal of the American Medical Assn., kicked up a firestorm of attention and skepticism.
A of Sparton Corp. (NYSE:SPA) subsidiary acquired Denver, Colo.-based Delphi Medical Systems contract manufacturing business.
The Schaumburg, Ill.-based manufacturing services provider’s Sparton Medical Systems Colorado LLC subsidiary bought Delphi’s manufacturing assets in a deal worth $8 million. Delphi primarily makes OEM medical devices for the therapeutic device market, including blood separation equipment, spinal surgery products and 3D eye mapping devices. The company also supports an environmental sensor firm for the meteorology and controlled environment applications markets.